Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

vTv Therapeutics Q4 EPS $(0.06), Inline, Sales $9.00K, Same YoY

vTv Therapeutics (NASDAQ:VTVT) reported quarterly losses of $(0.06) per share which met the analyst consensus estimate. This is a 45.45 percent increase over losses of $(0.11) per share from the same period last year.
byMichael Horton
March 6, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

vTv Therapeutics (NASDAQ:VTVT) reported quarterly losses of $(0.06) per share which met the analyst consensus estimate. This is a 45.45 percent increase over losses of $(0.11) per share from the same period last year. The company reported $9.00 thousand in sales this quarter. This is the same as the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0